Day One Biopharmaceuticals pany-Day One Biopharmaceuticals, Inc. (DAWN) Reports Q1 Loss, Tops Revenue Estimates

Day One Biopharmaceuticals, Inc. (DAWN) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of$ 0.46. This compares to loss of $0.72 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 23.91%. A quarter ago, it was expected that this company would post a loss of$ 0.35 per share when it actually produced a loss of $0.69, delivering a surprise of -97.14%.Over the last four quarters, the co ...